Loading...

Categories

10 Oman Hyperglycemics Reports

Middle East and Africa Diabetes Treatment Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer

Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company

Middle East And Africa Meglitinide Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Insulin Market

Country Covered: Oman

Study Period: 2018 - 2028

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Biguanides Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Meglitinide Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Oman

Study Period: 2018- 2028

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin Market

Country Covered: Oman

Study Period: 2018- 2028

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Insulin Glargine Market

Country Covered: Oman

Study Period: 2017- 2028

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar